Biologic Drugs With Physiological Effect: Increased Intravascular Volume

✉ Email this page to a colleague

Biologic Drugs With Physiological Effect: Increased Intravascular Volume

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Patent Expiration
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	1942-10-21	⤷ Sign Up	⤷ Sign Up
Grifols Therapeutics Llc	PLASMANATE	plasma protein fraction (human)	Injection	101140	1958-10-02	⤷ Sign Up	⤷ Sign Up
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	1954-03-03	⤷ Sign Up	⤷ Sign Up
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	1976-07-23	⤷ Sign Up	⤷ Sign Up
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	1978-08-15	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.